ViGenCell Inc. Logo

ViGenCell Inc.

Develops immune cell therapies to treat cancer and other incurable diseases.

308080 | KO

Overview

Corporate Details

ISIN(s):
KR7308080001
LEI:
Country:
South Korea
Address:
서울특별시 금천구 가산로9길 66 더리즌밸리 지식산업센터(가산동), 서울특별시

Description

ViGenCell Inc. is a biotechnology company specializing in the development of immune cell therapies. The company focuses on creating treatments for cancer and other incurable diseases by enhancing a patient's own immunity. Its core technologies include the ViTier platform, which utilizes antigen-specific killer T cells to target and remove cancer cells, and the ViRanger platform, a T-cell gene therapy technology. These proprietary platforms form the basis of its pipeline of novel immune cell therapeutics designed to prolong life and improve patient outcomes.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-02-26 00:00
주주총회소집결의
Korean 22.7 KB
2025-02-26 00:00
주주총회집중일개최사유신고
Korean 4.6 KB
2025-02-12 00:00
매출액또는손익구조30%(대규모법인은15%)이상변동
Korean 11.8 KB
2025-02-04 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 22.7 KB
2025-02-04 00:00
주식등의대량보유상황보고서(일반)
Korean 79.8 KB
2025-01-23 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 21.5 KB
2025-01-23 00:00
최대주주변경
Korean 26.8 KB
2024-12-24 00:00
주식등의대량보유상황보고서(일반)
Korean 81.8 KB
2024-12-20 00:00
주식등의대량보유상황보고서(일반)
Korean 98.6 KB
2024-12-20 00:00
주식등의대량보유상황보고서(일반)
Korean 85.3 KB
2024-12-18 00:00
최대주주변경을수반하는주식양수도계약체결
Korean 22.4 KB
2024-12-16 00:00
주주명부폐쇄기간또는기준일설정
Korean 4.3 KB
2024-11-14 00:00
분기보고서 (2024.09)
Korean 1.1 MB
2024-10-28 00:00
투자판단관련주요경영사항(임상시험계획자진취하등) (이식편대숙주질환 치료제 VMGD의 식품의약품안전처 제1/2a상 조기 종…
Korean 12.2 KB
2024-08-20 00:00
본점소재지변경
Korean 5.0 KB

Automate Your Workflow. Get a real-time feed of all ViGenCell Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ViGenCell Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for ViGenCell Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
Biotechnology company providing R&D and services for the life sciences sector.
Spain
IKM
2cureX AB Logo
Develops an IVD test using 3D tumoroids to predict patient response to cancer drugs.
Sweden
2CUREX
Abera Bioscience AB Logo
Develops mucosal vaccines using a proprietary Outer Membrane Vesicle (OMV) platform.
Sweden
ABERA
Clinical-stage biopharma developing therapeutics for oncology and viral diseases.
South Korea
203400
ABL Bio Inc. Logo
Develops bispecific antibody therapeutics for oncology and neurodegenerative diseases.
South Korea
298380
Abpro Holdings, Inc. Logo
Clinical-stage biotech developing antibody therapeutics for oncology and ophthalmology.
United States of America
ABP
Absci Corp Logo
A generative AI drug creation company developing biologic medicines.
United States of America
ABSI
Achiko AG Logo
A digital services platform for cross-border business compliance and engagement.
Switzerland
ACHI
Active Biotech Logo
Biotechnology company developing drugs for oncology and inflammatory eye disorders.
Sweden
ACTI
Adagene Inc. Logo
Clinical-stage biotech developing antibody-based immunotherapies for oncology.
United States of America
ADAG

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.